Cargando…

Bendamustine/ciclesonide/obinutuzumab: Diarrhoea following off-label use and prolonged viral shedding: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907324/ http://dx.doi.org/10.1007/s40278-021-91536-9

Ejemplares similares

Ciclesonide: Oral candidiasis following off-label use: case report
Publicado: (2021)

Bendamustine/rituximab: Prolonged SARS-CoV-2 viral shedding : case report
Publicado: (2022)

Prolonged COVID-19 in an Immunocompromised Patient Treated with Obinutuzumab and Bendamustine for Follicular Lymphoma
por: Ueda, Yayoi, et al.
Publicado: (2022)

Multiple drugs: Diarrhoea and prolonged viral shedding: 2 case reports
Publicado: (2020)

Bendamustine/obinutuzumab: COVID-19 disease, pancytopenia and hypogammaglobulinaemia: case report
Publicado: (2021)

Antineoplastics/ciclesonide/favipiravir: Pancytopenia and off-label use: case report
Publicado: (2022)

Multiple drugs: Prolonged viral shedding time and off-label use: case report
Publicado: (2020)

Prolonged SARS‐CoV‐2 infection during obinutuzumab and bendamustine treatment for follicular lymphoma: A case report
por: Kambe, Ryosuke, et al.
Publicado: (2023)

Hydrocortisone/prednisolone: Prolonged viral shedding and cystic fibrosis-related diabetes following off-label use: 2 case reports
Publicado: (2022)

Bendamustine/remdesivir/rituximab: Lymphocytopenia, hypogammaglobulinaemia and rebound viral shedding following drug resistance: case report
Publicado: (2022)

Ciclesonide/favipiravir/lopinavir/ritonavir: Off-label use, pancytopenia and liver dysfunction: case report
Publicado: (2021)

Multiple drugs: COVID-19 infection, prolonged viral shedding and off-label use: 2 case reports
Publicado: (2021)

Lopinavir/ritonavir: Diarrhoea following off label use: case report
Publicado: (2021)

Multiple drugs: Severe COVID-19, prolonged viral shedding, lack of efficacy and off-label use: case report
Publicado: (2022)

MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial
por: Pott, Christiane, et al.
Publicado: (2019)

Ciclesonide/iguratimod: Prolonged presence of SARS-CoV-2: case report
Publicado: (2020)

Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma
por: Grigg, Andrew, et al.
Publicado: (2017)

Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma
por: Younes, Anas, et al.
Publicado: (2022)

Bendamustine/obinutuzumab/remdesivir: Absence of CD19-B lymphocytes, decrease in CD4-T lymphocytes and lack of efficacy: case report
Publicado: (2021)

Multiple drugs: Off-label use and prolonged viral clearance: case report
Publicado: (2021)

Lopinavir/ritonavir/umifenovir: Nausea, vomiting and diarrhoea following off-label treatment: case report
Publicado: (2021)

Hydroxychloroquine: QTc prolongation following off-label-use: case report
Publicado: (2020)

Hydroxychloroquine: QTc-prolongation following an off-label use: case report
Publicado: (2020)

Hydroxychloroquine: QTc prolongation following off-label use: case report
Publicado: (2020)

Chloroquine: QTc prolongation following off-label use: case report
Publicado: (2022)

Multiple drugs: Diarrhoea following off label use, febrile neutropenia and lack of efficacy: case report
Publicado: (2020)

Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase Ib study (GO28440)
por: Stilgenbauer, Stephan, et al.
Publicado: (2020)

Persistent viral shedding of severe acute respiratory syndrome coronavirus 2 after treatment with bendamustine and rituximab: A case report()
por: Arai, Tatsuya, et al.
Publicado: (2022)

Hydroxychloroquine: Prolonged QT interval following off label use: case report
Publicado: (2020)

Hydroxychloroquine: Prolonged QTc interval following off-label use: case report
Publicado: (2020)

Hydroxychloroquine: QTc interval prolonged following off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: QT prolongation following off label use: case report
Publicado: (2022)

Hydroxychloroquine: QT interval prolongation following off-label use: case report
Publicado: (2022)

Atazanavir/ritonavir: QTc prolongation following off-label treatment: case report
Publicado: (2021)

Multiple drugs: Severe diarrhoea, off label use and treatment failure: case report
Publicado: (2022)

Antineoplastics: Prolonged COVID-19 viral shedding: 3 case reports
Publicado: (2021)

Multiple drugs: Prolonged COVID-19 viral shedding: case report
Publicado: (2021)

Antineoplastics: Prolonged viral shedding of COVID-19 pneumonia : case report
Publicado: (2021)

Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study
por: Stilgenbauer, Stephan, et al.
Publicado: (2018)

Hydroxychloroquine: Sinus bradycardia and QTc prolongation following off-label use: case report
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_seuambot0248dmf9g92q7uobtn